Difficulty: Medium
Average Score: 64%
Practice
The following are relative contraindications to the use of streptokinase in acute myocardial infarction EXCEPT:
Correct answer
C
Rationale
In the context of cardiovascular system drugs, particularly in the case of streptokinase use in acute myocardial infarction, selecting the correct answer and understanding why the other options are wrong is crucial for safe and effective patient care.
Correct Answer (C): Concurrent hormone replacement therapy for menopausal symptoms is NOT a relative contraindication to the use of streptokinase in acute myocardial infarction. This is because hormone replacement therapy does not directly interfere with the mechanism of action or increase the risk of adverse reactions when used alongside streptokinase.
Incorrect Answers:
A) Therapy with streptokinase from 5 days to 12 months previously: This is a relative contraindication as repeated use of streptokinase within a specific timeframe may lead to the development of antibodies against the drug, reducing its efficacy.
B) Stroke due to cerebral thrombosis in the last six months: This is a relative contraindication because of the increased risk of bleeding complications when using thrombolytic agents in patients with recent strokes.
D) Pulmonary disease with cavitation: This is a relative contraindication due to the risk of hemorrhage in patients with significant pulmonary disease.
Educational Context:
Understanding contraindications to medication use is vital for healthcare providers to make informed decisions regarding patient care. In the case of streptokinase, recognizing relative contraindications helps in minimizing risks and optimizing treatment outcomes for patients with acute myocardial infarction. This knowledge ensures safe and evidence-based practice in the management of cardiovascular emergencies.
Correct Answer (C): Concurrent hormone replacement therapy for menopausal symptoms is NOT a relative contraindication to the use of streptokinase in acute myocardial infarction. This is because hormone replacement therapy does not directly interfere with the mechanism of action or increase the risk of adverse reactions when used alongside streptokinase.
Incorrect Answers:
A) Therapy with streptokinase from 5 days to 12 months previously: This is a relative contraindication as repeated use of streptokinase within a specific timeframe may lead to the development of antibodies against the drug, reducing its efficacy.
B) Stroke due to cerebral thrombosis in the last six months: This is a relative contraindication because of the increased risk of bleeding complications when using thrombolytic agents in patients with recent strokes.
D) Pulmonary disease with cavitation: This is a relative contraindication due to the risk of hemorrhage in patients with significant pulmonary disease.
Educational Context:
Understanding contraindications to medication use is vital for healthcare providers to make informed decisions regarding patient care. In the case of streptokinase, recognizing relative contraindications helps in minimizing risks and optimizing treatment outcomes for patients with acute myocardial infarction. This knowledge ensures safe and evidence-based practice in the management of cardiovascular emergencies.